By utilizing 61 lacrimal scans, 26 patients who had received radiotherapy for inner canthus and lid lesions were evaluated. Results indicate that the membranous lacrimal passages are relatively immune to radiation therapy. Although dacryoscintigraphy did not delineate the anatomical features quite as well as contrast dacryocystography, it yielded very useful information about flow mechanisms and tear transit times. The study is rapid, simple, non-hazardous, and particularly helpful in documenting the status of the lacrimal drainage system before and after radiotherapy to the inner canthus region.

Download full-text PDF

Source
http://dx.doi.org/10.1148/116.2.373DOI Listing

Publication Analysis

Top Keywords

radiotherapy inner
8
inner canthus
8
effects radiotherapy
4
radiotherapy nasolacrimal
4
nasolacrimal system
4
system evaluated
4
evaluated dacryoscintigraphy
4
dacryoscintigraphy utilizing
4
utilizing lacrimal
4
lacrimal scans
4

Similar Publications

Irisquinone's Anti-cancer Potential: Targeting TrxR to Trigger ROS-mediated Apoptosis and Pyroptosis.

Anticancer Agents Med Chem

January 2025

Key Laboratory for Candidate Drug Design and Screening Based on Chemical Biology, College of Pharmacy, Inner Mongolia Medical University, Hohhot 010110, People's Republic of China.

Background: Irisquinone, an important compound extracted from Semen Irisis, has been used clinically as a radiotherapy sensitizer for lung, oesophageal, head and neck, breast and leukemia cancers. However, the mechanism by which it acts against cancer is still unclear.

Objective: The present study aims to investigate the anti-tumor activity and mechanism of Irisquinone.

View Article and Find Full Text PDF

Background: Gene methylation in cells is an important factor in tumorigenesis, and radiotherapy can change DNA methylation in cells. In this study, complete genome methylation sequencing (BS-Seq) technology was used to analyze the genome-wide methylation of patients with cervical cancer before and after radiotherapy.

Methods: Three pairs of cervical squamous cell carcinoma samples were collected from patients before and after radiotherapy in July 2020.

View Article and Find Full Text PDF

LZZAY01 accelerated autophagy and apoptosis in colon cancer cells and improved gut microbiota in CAC mice.

Microbiol Spectr

January 2025

Laboratory of Microbiology and Immunology, School of Basic Medical Science, Inner Mongolia Medical University, Hohhot, China.

Colorectal cancer (CRC) is one of the malignant tumors globally, with high morbidity and mortality rates. The mainstay treatment of CRC includes surgery, radiotherapy, and chemotherapy. However, these treatments are associated with a high recurrence rate, poor prognosis, and highly toxic side effects.

View Article and Find Full Text PDF
Article Synopsis
  • Developing 3D cell cultures from glioma cell lines can enhance tumor therapy research by mimicking patient tumors more closely than traditional 2D cultures.
  • The study focused on optimizing parameters for high-throughput screening, analyzing how initial cell numbers and culture time affect spheroid growth and viability.
  • Key findings showed that fewer initial cells led to better growth in spheroids, highlighting the potential for improved testing of treatments like temozolomide and radiation in more representative tumor models.
View Article and Find Full Text PDF

Background: Cisplatin (DDP) resistance has long posed a challenge in the clinical treatment of lung cancer (LC). Insulin-like growth factor 2 binding protein 2 (IGF2BP2) has been identified as an oncogenic factor in LC, whereas its specific role in DDP resistance in LC remains unclear.

Results: In this study, we investigated the role of IGF2BP2 on DDP resistance in DDP-resistant A549 cells (A549/DDP) in vitro and in a DDP-resistant lung tumor-bearing mouse model in vivo.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!